RNA Q1 2023 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+24.4% YoY

Gross Profit

-$46M-2039.1% margin

Operating Income

-$58M-2579.3% margin

Net Income

-$52M-2346.4% margin

EPS (Diluted)

$-0.67

QoQ Revenue Growth

-19.4%

Cash Flow

Operating Cash Flow

-$49M

Free Cash Flow

-$51M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$614M

Total Liabilities

$55M

Stockholders' Equity

$559M

Cash & Equivalents

$119M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+24.4%
Gross Profit	-$46M	-$26M	-75.8%
Operating Income	-$58M	-$34M	-67.1%
Net Income	-$52M	-$34M	-53.0%